TFO
WST icon

Tarbox Family Office’s West Pharmaceutical WST Stock Holding History

Tarbox Family Office’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5
Closed -$2K – 988
2022
Q1 		$2K Sell
5
-12
-71% -$4.7K ﹤0.01% 882
2021
Q4 		$8K Buy
17
+12
+240% +$5.17K ﹤0.01% 501
2021
Q3 		$2K Hold
5
– – ﹤0.01% 987
2021
Q2 		$2K Hold
5
– – ﹤0.01% 997
2021
Q1 		$1K Hold
5
– – ﹤0.01% 1102
2020
Q4 		$1K Buy
+5
New +$1.4K ﹤0.01% 1081
2020
Q1 		– Sell
-11
Closed -$2K – 1345
2019
Q4 		$2K Hold
11
– – ﹤0.01% 873
2019
Q3 		$2K Hold
11
– – ﹤0.01% 808
2019
Q2 		$1K Buy
+11
New +$1.3K ﹤0.01% 1040

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Tarbox Family Office's WST Position: Q2 2022 in Review

Tarbox Family Office sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 5 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in WST in Q2 2019 and held it in 9 quarters. The position peaked at $8K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Tarbox Family Office reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 5 West Pharmaceutical shares in Q2 2022, an estimated $2K.
  • Tarbox Family Office first reported a position in West Pharmaceutical in Q2 2019 and held it in 9 quarters.
  • Tarbox Family Office's West Pharmaceutical position peaked at $8K in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.